- Home
- BDTX
as 06-30-2025 3:30pm EST
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 132.5M | IPO Year: | 2020 |
| Target Price: | $15.60 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.20 - $6.75 | Next Earning Date: | 08-05-2025 |
| Revenue: | $70,000,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Black Diamond Therapeutics Inc. News
BDTX Breaking Stock News: Dive into BDTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
2 months ago
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Simply Wall St.
2 months ago
Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year
GlobeNewswire
3 months ago
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
Pharmaceutical Technology
3 months ago
Servier and Black Diamond sign deal for solid tumours therapy
MT Newswires
3 months ago
Sector Update: Health Care
MT Newswires
3 months ago
Top Midday Gainers
MT Newswires
3 months ago
Black Diamond Therapeutics, Servier Sign Global Licensing Deal for BDTX-4933 to Treat Solid Tumors
Compare BDTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDTX Black Diamond Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.